Case number 2019-1369
Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 18, 2020 | 17 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [671868] [19-1368, 19-1369] [MJL] [Entered: 02/18/2020 08:15 AM] (0) |
| Nov 20, 2019 | 16 | ERRATA to the Nonprecedential Opinion Doc No.: [14]. Service as of this date by the Clerk of Court. [650763] [19-1368, 19-1369] [JAB] [Entered: 11/20/2019 09:45 AM] (0) |
| Nov 19, 2019 | 14 | OPINION filed for the court by Newman, Circuit Judge; Taranto, Circuit Judge and Chen, Circuit Judge. Dissenting opinion filed by Circuit Judge Newman. Nonprecedential Opinion. [650422] [19-1368, 19-1369] [JAB] [Entered: 11/19/2019 09:24 AM] (0) |
| Nov 19, 2019 | 15 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [650423] [19-1368, 19-1369] [JAB] [Entered: 11/19/2019 09:25 AM] (0) |
| Feb 27, 2019 | 13 | Certified list from the United States Patent and Trademark Office. Service: 02/19/2019 by email. [589041] [TAM] [Entered: 02/27/2019 12:09 PM] (0) |
| Jan 31, 2019 | 12 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: certificate of interest Docket No. [10], docketing statement Docket No. [11], ERROR: The certificate of interest [10] and docketing statement [11] were filed in the member case of a consolidated group. CORRECTION: All filings should be made in the lead case only, 19-1368. Any future filings in the member case, 19-1369, will be non-compliant. As these documents were also filed in the lead case, no further action is necessary. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [582285] [JAL] [Entered: 01/31/2019 08:51 AM] (0) |
| Jan 22, 2019 | 10 | Certificate of Interest for the Appellee Mylan Pharmaceuticals Inc.. Service: 01/22/2019 by email. [579892] [19-1369] [Richard Torczon] [Entered: 01/22/2019 04:37 PM] (0) |
| Jan 22, 2019 | 11 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 01/22/2019 by email. [579898] [19-1369] [Richard Torczon] [Entered: 01/22/2019 04:38 PM] (0) |
| Jan 18, 2019 | 8 | Note to file: The following cases are associated: 19-1368 (Lead) with 19-1369 (Member Case). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [579225] [19-1368, 19-1369] [TAM] [Entered: 01/18/2019 09:15 AM] (0) |
| Jan 18, 2019 | 9 | Corrected Entry of appearance for Douglas H. Carsten as principal counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/18/2019 by email. [579248] [19-1369] [Richard Torczon] [Entered: 01/18/2019 10:34 AM] (0) |
| Jan 18, 2019 | 7 | ORDER consolidating appeals (19-1368 with 19-1369). Service as of this date by the Clerk of Court. [579224] [19-1368, 19-1369] [TAM] [Entered: 01/18/2019 09:05 AM] (2) |
| Jan 17, 2019 | 6 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Mylan Pharmaceuticals Inc., Entry of Appearance-Douglas Carsten [2], is not in compliance with the rules of this court (see attached). Compliant document due on 01/25/2019. Service as of this date by the Clerk of Court.[579130] [TAM] [Entered: 01/17/2019 04:31 PM] (1) |
| Jan 16, 2019 | 2 | Entry of appearance for Douglas H. Carsten as principal counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578675] [19-1369] This document is non-compliant. See Doc No. [6] [Richard Torczon] [Entered: 01/16/2019 03:41 PM] (2) |
| Jan 16, 2019 | 3 | Entry of appearance for Richard Torczon as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578677] [19-1369] [Richard Torczon] [Entered: 01/16/2019 03:43 PM] (2) |
| Jan 16, 2019 | 4 | Entry of appearance for Elham F. Steiner as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578680] [19-1369] [Richard Torczon] [Entered: 01/16/2019 03:45 PM] (2) |
| Jan 16, 2019 | 5 | Entry of appearance for Nicole W. Stafford as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578712] [19-1369] [Richard Torczon] [Entered: 01/16/2019 04:12 PM] (2) |
| Jan 7, 2019 | 1 | Appeal docketed. Received: 01/04/2019. [576176] Entry of Appearance due 01/22/2019. Certificate of Interest is due on 01/22/2019. Docketing Statement due 01/22/2019. Certified List due on 02/19/2019. [TAM] [Entered: 01/07/2019 10:19 AM] (60) |
